| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/27/2023 | 12.11% | Piper Sandler | $120 → $140 | Maintains | Overweight |
| 01/12/2023 | 9.71% | Jefferies | $112 → $137 | Maintains | Buy |
| 01/12/2023 | 4.1% | Needham | $120 → $130 | Maintains | Buy |
| 12/05/2022 | -11.11% | Goldman Sachs | $100 → $111 | Maintains | Buy |
| 10/27/2022 | -19.92% | Goldman Sachs | $89 → $100 | Maintains | Buy |
| 10/27/2022 | -3.91% | Needham | $102 → $120 | Maintains | Buy |
| 07/28/2022 | -28.73% | Goldman Sachs | $78 → $89 | Maintains | Buy |
| 07/28/2022 | -19.92% | Piper Sandler | $80 → $100 | Maintains | Overweight |
| 07/28/2022 | -18.32% | Needham | $96 → $102 | Maintains | Buy |
| 04/28/2022 | -35.94% | Piper Sandler | $100 → $80 | Maintains | Overweight |
| 03/28/2022 | -27.93% | Goldman Sachs | $102 → $90 | Maintains | Buy |
| 01/12/2022 | -19.92% | Canaccord Genuity | $95 → $100 | Maintains | Buy |
| 01/12/2022 | -23.13% | Needham | $63 → $96 | Maintains | Buy |
| 12/15/2021 | -19.92% | Jefferies | → $100 | Initiates Coverage On | → Buy |
| 11/17/2021 | -23.93% | Canaccord Genuity | $75 → $95 | Maintains | Buy |
| 10/28/2021 | -49.55% | Needham | $55 → $63 | Maintains | Buy |
| 10/26/2021 | -44.75% | Lake Street | → $69 | Initiates Coverage On | → Buy |
| 07/29/2021 | -55.96% | Needham | $66 → $55 | Maintains | Buy |
| 04/29/2021 | -47.15% | Needham | $77 → $66 | Maintains | Buy |
| 02/11/2021 | -39.94% | Canaccord Genuity | $55 → $75 | Maintains | Buy |
| 02/11/2021 | -35.94% | Piper Sandler | $60 → $80 | Maintains | Overweight |
| 02/11/2021 | -53.56% | Morgan Stanley | $53 → $58 | Maintains | Equal-Weight |
| 02/11/2021 | -38.34% | Needham | $61 → $77 | Maintains | Buy |
| 01/19/2021 | -57.56% | Morgan Stanley | $38 → $53 | Maintains | Equal-Weight |
| 01/19/2021 | -51.15% | Needham | $30 → $61 | Maintains | Buy |
| 12/14/2020 | -69.57% | Morgan Stanley | $26 → $38 | Maintains | Equal-Weight |
| 11/30/2020 | -63.16% | Goldman Sachs | → $46 | Initiates Coverage On | → Buy |
| 10/29/2020 | -76.78% | Piper Sandler | $28 → $29 | Maintains | Overweight |
| 10/29/2020 | -71.97% | Canaccord Genuity | $32 → $35 | Maintains | Buy |
| 07/30/2020 | -77.58% | Piper Sandler | $35 → $28 | Maintains | Overweight |
| 07/30/2020 | -79.18% | Morgan Stanley | $28 → $26 | Maintains | Equal-Weight |
| 07/30/2020 | -75.98% | Needham | $34 → $30 | Maintains | Buy |
| 07/10/2020 | -72.77% | Needham | $25 → $34 | Maintains | Buy |
| 06/16/2020 | -77.58% | Morgan Stanley | $21 → $28 | Maintains | Equal-Weight |
| 04/28/2020 | -79.98% | Needham | $19 → $25 | Maintains | Buy |
| 04/27/2020 | -83.18% | Morgan Stanley | $22 → $21 | Maintains | Equal-Weight |
| 03/19/2020 | -84.79% | Needham | $33 → $19 | Maintains | Buy |
| 03/18/2020 | -82.38% | Morgan Stanley | $31 → $22 | Maintains | Equal-Weight |
| 03/04/2020 | -75.98% | RBC Capital | $36 → $30 | Maintains | Sector Perform |
| 01/21/2020 | -72.77% | Needham | $32 → $34 | Maintains | Buy |
| 12/17/2019 | -74.38% | Needham | → $32 | Upgrades | Hold → Buy |
| 07/30/2019 | -67.97% | Piper Sandler | $32 → $40 | Maintains | Overweight |
| 07/01/2019 | — | Dougherty & Co. | Upgrades | Neutral → Buy | |
| 05/08/2018 | — | Canaccord Genuity | Upgrades | Hold → Buy | |
| 02/15/2018 | -86.39% | Canaccord Genuity | $20 → $17 | Maintains | Hold |
| 02/06/2018 | — | Piper Sandler | Upgrades | Neutral → Overweight | |
| 02/05/2018 | -88.79% | Morgan Stanley | $27 → $14 | Maintains | Equal-Weight |
| 02/02/2018 | -85.59% | Piper Sandler | $27.5 → $18 | Maintains | Neutral |
| 02/02/2018 | -86.39% | RBC Capital | → $17 | Downgrades | Outperform → Sector Perform |
| 02/02/2018 | -83.98% | Canaccord Genuity | $35 → $20 | Downgrades | Buy → Hold |
What is the target price for Impinj (PI)?
The latest price target for Impinj (NASDAQ: PI) was reported by Piper Sandler on January 27, 2023. The analyst firm set a price target for $140.00 expecting PI to rise to within 12 months (a possible 12.11% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Impinj (PI)?
The latest analyst rating for Impinj (NASDAQ: PI) was provided by Piper Sandler, and Impinj maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Impinj (PI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Impinj, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Impinj was filed on January 27, 2023 so you should expect the next rating to be made available sometime around January 27, 2024.
Is the Analyst Rating Impinj (PI) correct?
While ratings are subjective and will change, the latest Impinj (PI) rating was a maintained with a price target of $120.00 to $140.00. The current price Impinj (PI) is trading at is $124.88, which is within the analyst's predicted range.